UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer

Cancer science, 2019-03, Vol.110 (3), p.1012-1020

2019

Volltextzugriff (PDF)

The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis

PloS one, 2017-03, Vol.12 (3), p.e0174547-e0174547

2017

Volltextzugriff (PDF)

Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer

Biological and Pharmaceutical Bulletin, 2016/12/01, Vol.39(12), pp.2009-2014

2016

Volltextzugriff (PDF)

A Retrospective Cohort Study of Outcome in Systemic Sclerosis-associated Interstitial Lung Disease

Respiratory investigation, 2016-11, Vol.54 (6), p.445-453

2016

Volltextzugriff (PDF)

Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer

Biological and Pharmaceutical Bulletin, 2016-12, Vol.39 (12), p.2009-2014

2016

Volltextzugriff (PDF)

Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Lung cancer (Amsterdam, Netherlands), 2019-10, Vol.136, p.45-51

2019

Volltextzugriff (PDF)

Successful Treatment with Tacrolimus in a Case of Lung-dominant Connective Tissue Disease

Internal Medicine, 2013, Vol.52(5), pp.605-609

2013

Volltextzugriff (PDF)

The risk factors for mortality of community-acquired pneumonia in Japan

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2007-06, Vol.13 (3), p.157-165

2007

Volltextzugriff (PDF)

Lung Adenocarcinoma Metastasis to the Male Breast: A Case Report

The Kurume Medical Journal, 2014/06/30, Vol.61(1.2), pp.35-41

2014

Volltextzugriff (PDF)

A long-term survivor with late-onset-repeated pulmonary metastasis of a PEComa

Annals of thoracic and cardiovascular surgery, 2010-12, Vol.16 (6), p.429-431

2010

Volltextzugriff (PDF)

Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2019-11, Vol.24 (11), p.1420-e1010

2019

Volltextzugriff (PDF)

Gefitinib Plus Bevacizumab vs . Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer

In vivo (Athens), 2019-03, Vol.33 (2), p.477-482

2019

Volltextzugriff (PDF)

Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2020-03, Vol.25 (3), p.208-e417

2020

Volltextzugriff (PDF)

Clinical Efficacy of the Transdermal Tulobuterol Patch in Patients with Chronic Obstructive Pulmonary Disease: A Comparison with Slow-Release Theophylline

Internal Medicine, 2008, Vol.47(6), pp.503-509

2008

Volltextzugriff (PDF)

Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801

The oncologist (Dayton, Ohio), 2020-08, Vol.25 (8), p.e1146-e1157

2020

Volltextzugriff (PDF)

Elevation of pulmonary CD163 + and CD204 + macrophages is associated with the clinical course of idiopathic pulmonary fibrosis patients

Journal of thoracic disease, 2019-09, Vol.11 (9), p.4005-4017

2019

Volltextzugriff (PDF)

Phase II trial of carboplatin and pemetrexed plus bevacizumab with maintenance bevacizumab as first-line treatment for elderly patients with advanced non-squamous non-small cell lung cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.e21180-e21180

2018

Volltextzugriff (PDF)

Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients

Anticancer research, 2018-06, Vol.38 (6), p.3779-3784

2018

Volltextzugriff (PDF)

Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)

Lung cancer (Amsterdam, Netherlands), 2019-06, Vol.132, p.1-8

2019

Volltextzugriff (PDF)

Phase II study of carboplatin and amrubicin with a biweekly schedule in patients with advanced squamous cell lung cancer: Interim analysis

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e19141-e19141

2014

Volltextzugriff (PDF)

Efficacy and safety of bevacizumab in nonsquamous non-small cell lung cancer with brain metastases

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e19134-e19134

2013

Volltextzugriff (PDF)

A multicenter phase II study of low-dose erlotinib in frail patients with EGFR mutation-positive, non-small cell lung cancer: Thoracic oncology research group (TORG) trial 1425

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.9063-9063

2018

Volltextzugriff (PDF)

Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer

OncoTargets and therapy, 2017-01, Vol.10, p.5107-5113

2017

Volltextzugriff (PDF)

A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer

Cancer chemotherapy and pharmacology, 2016-09, Vol.78 (3), p.501-507

2016

Volltextzugriff (PDF)

A multicenter phase II study of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e19040-e19040

2015

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(68)
Japanisch
(16)

Erscheinungsjahr

n.n

Thema

Male
(44)
Science & Technology
(42)
Humans
(41)
Life Sciences & Biomedicine
(37)
Female
(32)
Aged
(26)
Middle Aged
(26)
Adult
(19)
Oncology
(17)
Lung Neoplasms - Drug Therapy
(15)
Biological And Medical Sciences
(14)
Lung Cancer
(14)
Medical Sciences
(14)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(12)
Treatment Outcome
(12)
Chemotherapy
(11)
Pharmacology. Drug Treatments
(11)
Pharmacology & Pharmacy
(10)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(9)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

KEYNOTE‐025: Phase 1b study of pembrolizumab in Japanese patients with previously treated programmed death ligand 1–positive advanced non–small‐cell lung cancer

The usefulness of monomeric periostin as a biomarker for idiopathic pulmonary fibrosis

Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer

A Retrospective Cohort Study of Outcome in Systemic Sclerosis-associated Interstitial Lung Disease

Risk Factors Associated with Cisplatin-Induced Nephrotoxicity in Patients with Advanced Lung Cancer

Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors

Successful Treatment with Tacrolimus in a Case of Lung-dominant Connective Tissue Disease

The risk factors for mortality of community-acquired pneumonia in Japan

Lung Adenocarcinoma Metastasis to the Male Breast: A Case Report

A long-term survivor with late-onset-repeated pulmonary metastasis of a PEComa

Randomized Phase II Study of Weekly Paclitaxel plus Carboplatin Versus Biweekly Paclitaxel plus Carboplatin for Patients with Previously Untreated Advanced Non‐Small Cell Lung Cancer

Gefitinib Plus Bevacizumab vs . Gefitinib Alone for EGFR Mutant Non-squamous Non-small Cell Lung Cancer

Phase II Study on Biweekly Combination Therapy of Gemcitabine plus Carboplatin for the Treatment of Elderly Patients with Advanced Non‐Small Cell Lung Cancer

Clinical Efficacy of the Transdermal Tulobuterol Patch in Patients with Chronic Obstructive Pulmonary Disease: A Comparison with Slow-Release Theophylline

Randomized Phase II Study of First‐Line Biweekly Gemcitabine and Carboplatin Versus Biweekly Gemcitabine and Carboplatin plus Maintenance Gemcitabine in Elderly Patients with Untreated Non‐Small Cell Lung Cancer: LOGIK0801

Elevation of pulmonary CD163 + and CD204 + macrophages is associated with the clinical course of idiopathic pulmonary fibrosis patients

Phase II trial of carboplatin and pemetrexed plus bevacizumab with maintenance bevacizumab as first-line treatment for elderly patients with advanced non-squamous non-small cell lung cancer

Phase II Trial of Carboplatin and Pemetrexed Plus Bevacizumab with Maintenance Bevacizumab as a First-line Treatment for Advanced Non-squamous Non-small Cell Lung Cancer in Elderly Patients

Randomized phase II study of pemetrexed or pemetrexed plus bevacizumab for elderly patients with previously untreated non-squamous non-small cell lung cancer: Results of the Lung Oncology Group in Kyushu (LOGIK1201)

Phase II study of carboplatin and amrubicin with a biweekly schedule in patients with advanced squamous cell lung cancer: Interim analysis

Efficacy and safety of bevacizumab in nonsquamous non-small cell lung cancer with brain metastases

A multicenter phase II study of low-dose erlotinib in frail patients with EGFR mutation-positive, non-small cell lung cancer: Thoracic oncology research group (TORG) trial 1425

Preventive effect of kampo medicine (hangeshashin-to, TJ-14) plus minocycline against afatinib-induced diarrhea and skin rash in patients with non-small cell lung cancer

A multicenter phase II trial of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer

A multicenter phase II study of S-1 combined with bevacizumab after platinum-based chemotherapy in patients with advanced non-squamous non-small cell lung cancer

Suchergebnisse filtern